GDMT, Medicine

People

  1. Kyi
    Kyi
  2. Grisham
    Grisham
  3. Tew
    Tew
  4. Cohen
    Cohen
  5. Konner
    Konner
  6. Troso-Sandoval
    Troso-Sandoval
  7. Aghajanian
    Aghajanian
  8. Liu
    Liu
  9. Zlobinsky
    Zlobinsky
  10. Makker
    Makker
  11. O'Cearbhaill
    O'Cearbhaill
  12. Gorsky
    Gorsky
  13. Guo
    Guo
  14. Osorio
    Osorio
  15. Hensley
    Hensley

Description

Publications

  1. Journal of Clinical Oncology (420)
  2. Gynecologic Oncology (416)
  3. International Journal of Gynecological Cancer (152)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (64)
  6. Cancer Research (37)
  7. Cancer (37)
  8. Journal for ImmunoTherapy of Cancer (35)
  9. Modern Pathology (31)
  10. Gynecologic Oncology Reports (27)

Publishers

  1. Elsevier Inc. (496)
  2. American Society of Clinical Oncology (447)
  3. Lippincott Williams & Wilkins (177)
  4. Oxford University Press (114)
  5. American Association for Cancer Research (100)
  6. Nature Publishing Group (71)
  7. Wiley Blackwell (56)
  8. Springer (51)
  9. Biomed Central Ltd (41)
  10. American Association for Cancer Research (39)

Belongs to

Types of Work

Recent Works

  1. Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  2. A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  3. ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma
    Journal Article

    Liu, J. F.; Colombo, N.; Oza, A. M.; Frenel, J. S.; Corr, B. R.; Rubinstein, M. M.; Nevadunsky, N. S.; Lheureux, S.; Gaba, L.; González Cortijo, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save